BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26277616)

  • 1. Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.
    DePalo J; Chai X; Lee SJ; Cutler CS; Treister N
    Oral Oncol; 2015 Oct; 51(10):944-9. PubMed ID: 26277616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of oral chronic graft-versus-host disease.
    Treister NS; Cook EF; Antin J; Lee SJ; Soiffer R; Woo SB
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):110-5. PubMed ID: 18158967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.
    Pidala J; Kurland B; Chai X; Majhail N; Weisdorf DJ; Pavletic S; Cutler C; Jacobsohn D; Palmer J; Arai S; Jagasia M; Lee SJ
    Blood; 2011 Apr; 117(17):4651-7. PubMed ID: 21355084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic graft-versus-host disease on quality of life and cognitive function of long-term transplant survivors after allogeneic hematopoietic stem cell transplantation with total body irradiation.
    Gruber I; Koelbl O; Herr W; Holler E; Edinger M; Wolff D
    Radiat Oncol; 2022 Nov; 17(1):195. PubMed ID: 36447269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
    Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms, Cytokines, and Quality of Life in Patients Diagnosed with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Lynch Kelly D; Lyon DE; Ameringer SA; Elswick RK
    Oncol Nurs Forum; 2015 May; 42(3):265-75. PubMed ID: 25901378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.
    Vasconcellos de Souza C; Vigorito AC; Miranda ECM; Garcia C; Rensi Colturato VA; Mauad MA; Rodrigues Moreira MC; da Silva Bouzas LF; Lermontov S; Hamerschlak N; Rodrigues M; Carlos de Almeida Barros J; Chiattone R; Lee SJ; Flowers MED
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1313-1318. PubMed ID: 27058616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?
    Perić Z; Desnica L; Duraković N; Ostojić A; Pulanić D; Serventi-Seiwerth R; Prenc E; Basak G; Vrhovac R; Pavletic SZ; Nemet D
    Croat Med J; 2016 Feb; 57(1):6-15. PubMed ID: 26935610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
    Elad S; Levitt M; M Y S
    Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease.
    Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ;
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
    Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
    Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
    Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital chronic graft-versus-host disease in females: a cross-sectional study.
    Smith Knutsson E; Björk Y; Broman AK; Helström L; Levin Jakobsen AM; Nilsson O; Sundfeldt K; Brune M
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):806-11. PubMed ID: 24594123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
    Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral chronic GVHD outcomes and resource utilization: a subanalysis from the chronic GVHD consortium.
    Yuan A; Chai X; Martins F; Arai S; Arora M; Correa ME; Pidala J; Cutler CS; Lee SJ; Treister NS
    Oral Dis; 2016 Apr; 22(3):235-40. PubMed ID: 26708609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
    Lee Sk; Cook EF; Soiffer R; Antin JH
    Biol Blood Marrow Transplant; 2002; 8(8):444-52. PubMed ID: 12234170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.
    Kurosawa S; Yamaguchi T; Oshima K; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):1851-1858. PubMed ID: 31129353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive dental caries in patients with oral chronic graft-versus-host disease.
    Castellarin P; Stevenson K; Biasotto M; Yuan A; Woo SB; Treister NS
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1573-9. PubMed ID: 22516054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.
    Lutz M; Kapp M; Einsele H; Grigoleit GU; Mielke S
    Clin Transplant; 2014 Dec; 28(12):1410-5. PubMed ID: 25287756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients.
    Noce CW; Gomes A; Copello A; Barbosa RD; Sant'anna S; Moreira MC; Correa ME; Maiolino A; Torres SR
    Gen Dent; 2011; 59(6):458-62; quiz 463-4. PubMed ID: 22313917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.